Chemoattractants MDC And TARC Are Secreted By Malignant B-cell ...

Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search: Search Advanced Clipboard Save Email Send to

• Clipboard
• My Bibliography
• Collections
• Citation manager

Display options Display options Format Abstract PubMed PMID

Save citation to file

Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel

Email citation

Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel

Add to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Please try again Add Cancel

Add to My Bibliography

• My Bibliography

Unable to load your delegates due to an error Please try again Add Cancel

Your saved search

Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons

• Yes
• No

Email: (change) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel

Create a file for external citation management software

Create file Cancel

Your RSS Feed

Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy

Full text links

Silverchair Information Systems Elsevier Science Full text links

Actions

CiteCollectionsAdd to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an errorPlease try again Add Cancel PermalinkPermalinkCopyDisplay options Display options Format AbstractPubMedPMID

Page navigation

• Title & authors
• Abstract
• Publication types
• MeSH terms
• Substances
• Grants and funding
• LinkOut - more resources

Title & authors Abstract Publication types MeSH terms Substances Grants and funding LinkOut - more resources Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

The use of tumor cells as vaccines in cancer immunotherapy is critically dependent on their capacity to initiate and amplify tumor-specific immunity. Optimal responses may require the modification of the tumor cells not only to increase their immunogenicity but also to improve their ability to recruit effector cells to the tumor sites or sites of tumor antigen exposure. It has been reported that CD40 cross-linking of acute lymphoblastic leukemia (ALL) cells significantly increases their immunogenicity and allows the generation and expansion of autologous antileukemia cytotoxic T lymphocytes. This study demonstrates that the CD40 ligation of these tumor cells also induces the secretion of the CC-chemokines MDC and TARC. Supernatants from malignant cells cultured in the presence of sCD40L promote the migration of activated T cells that express CCR4, the common specific receptor for MDC and TARC. More importantly, the supernatants from CD40-stimulated tumor cells also support the transendothelial migration of autologous CCR4(+) antileukemia T cells. Therefore, the results demonstrate that the delivery to leukemia cells of a single physiologic signal, that is, CD40 cross-linking, simultaneously improves tumor cell immunogenicity and induces potent chemoattraction for T cells. (Blood. 2001;98:533-540)

PubMed Disclaimer

Publication types

• Research Support, Non-U.S. Gov't Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Research Support, U.S. Gov't, P.H.S. Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

MeSH terms

• Antigen Presentation Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Antigens, Neoplasm Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• B-Lymphocytes / immunology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• B-Lymphocytes / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• B-Lymphocytes / pathology* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Burkitt Lymphoma / immunology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Burkitt Lymphoma / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Burkitt Lymphoma / pathology* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CD40 Antigens / metabolism* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CD40 Ligand / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Cell Movement / drug effects* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Chemokine CCL17 Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Chemokine CCL22 Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Chemokines, CC / metabolism* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Chemokines, CC / pharmacology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Chemotactic Factors / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Chemotactic Factors / pharmacology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Hematopoietic Stem Cells / immunology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Hematopoietic Stem Cells / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Hematopoietic Stem Cells / pathology* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Protein Binding Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• T-Lymphocytes, Cytotoxic / cytology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• T-Lymphocytes, Cytotoxic / drug effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• T-Lymphocytes, Cytotoxic / immunology* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• Antigens, Neoplasm Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CCL17 protein, human Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CCL22 protein, human Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CD40 Antigens Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Chemokine CCL17 Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Chemokine CCL22 Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Chemokines, CC Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Chemotactic Factors Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CD40 Ligand Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Grants and funding

• P01-CA66996/CA/NCI NIH HHS/United States
• P01-CA68484/CA/NCI NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

Full text links [x] Silverchair Information Systems Elsevier Science [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To

• Clipboard
• Email
• Save
• My Bibliography
• Collections
• Citation Manager

[x]

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.